Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Pigment Cell Melanoma Res ; 36(5): 365-377, 2023 09.
Article in English | MEDLINE | ID: mdl-37341054

ABSTRACT

An increasing number of cancer subtypes are treated with front-line immunotherapy. However, approaches to overcome primary and acquired resistance remain limited. Preclinical mouse models are often used to investigate resistance mechanisms, novel drug combinations, and delivery methods; yet most of these models lack the genetic diversity and mutational patterns observed in human tumors. Here we describe a series of 13 C57BL/6J melanoma cell lines to address this gap in the field. The Ohio State University-Moffitt Melanoma Exposed to Radiation (OSUMMER) cell lines are derived from mice expressing endogenous, melanocyte-specific, and clinically relevant Nras driver mutations (Q61R, Q61K, or Q61L). Exposure of these animals to a single, non-burning dose of ultraviolet B accelerates the onset of spontaneous melanomas with mutational patterns akin to human disease. Furthermore, in vivo irradiation selects against potent tumor antigens, which could prevent the outgrowth of syngeneic cell transfers. Each OSUMMER cell line possesses distinct in vitro growth properties, trametinib sensitivity, mutational signatures, and predicted antigenicity. Analysis of OSUMMER allografts shows a correlation between strong, predicted antigenicity and poor tumor outgrowth. These data suggest that the OSUMMER lines will be a valuable tool for modeling the heterogeneous responses of human melanomas to targeted and immune-based therapies.


Subject(s)
Cell Line, Tumor , Melanoma , Animals , Mice , Cell Line, Tumor/radiation effects , GTP Phosphohydrolases/genetics , Melanoma/drug therapy , Melanoma/genetics , Melanoma/pathology , Membrane Proteins/genetics , Mice, Inbred C57BL , Mutation/genetics , Proto-Oncogene Proteins B-raf/genetics
2.
Pigment Cell Melanoma Res ; 36(1): 6-18, 2023 01.
Article in English | MEDLINE | ID: mdl-36148789

ABSTRACT

Melanin is a free-radical scavenger, antioxidant, and broadband absorber of ultraviolet (UV) radiation which protects the skin from environmental carcinogenesis. However, melanin synthesis and UV-induced reactive melanin species are also implicated in melanocyte genotoxicity. Here, we attempted to reconcile these disparate functions of melanin using a UVB-sensitive, NRAS-mutant mouse model, TpN. We crossed TpN mice heterozygous for an inactivating mutation in Tyrosinase to produce albino and black littermates on a C57BL/6J background. These animals were then exposed to a single UVB dose on postnatal day three when keratinocytes in the skin have yet to be melanized. Approximately one-third (35%) of black mice were protected from UVB-accelerated tumor formation. However, melanoma growth rates, tumor mutational burdens, and gene expression profiles were similar in melanomas from black and albino mice. Skin from albino mice contained more cyclobutane pyrimidine dimer (CPD) positive cells than black mice 1-h post-irradiation. However, this trend gradually reversed over time with CPDs becoming more prominent in black than albino melanocytes at 48 h. These results show that in the absence of epidermal pigmentation, melanocytic melanin limits the tumorigenic effects of acute UV exposure but fails to protect melanocytes from UVB-induced mutagenesis.


Subject(s)
Melanoma , Skin Neoplasms , Mice , Animals , Melanins/metabolism , Skin Neoplasms/pathology , Mice, Inbred C57BL , Melanocytes/metabolism , Melanoma/pathology , Ultraviolet Rays , Mutagenesis
3.
Cancer Res ; 82(22): 4261-4273, 2022 11 15.
Article in English | MEDLINE | ID: mdl-36112789

ABSTRACT

Mutationally activated BRAF is detected in approximately 7% of human lung adenocarcinomas, with BRAFT1799A serving as a predictive biomarker for treatment of patients with FDA-approved inhibitors of BRAFV600E oncoprotein signaling. In genetically engineered mouse (GEM) models, expression of BRAFV600E in the lung epithelium initiates growth of benign lung tumors that, without additional genetic alterations, rarely progress to malignant lung adenocarcinoma. To identify genes that cooperate with BRAFV600E for malignant progression, we used Sleeping Beauty-mediated transposon mutagenesis, which dramatically accelerated the emergence of lethal lung cancers. Among the genes identified was Rbms3, which encodes an RNA-binding protein previously implicated as a putative tumor suppressor. Silencing of RBMS3 via CRISPR/Cas9 gene editing promoted growth of BRAFV600E lung organoids and promoted development of malignant lung cancers with a distinct micropapillary architecture in BRAFV600E and EGFRL858R GEM models. BRAFV600E/RBMS3Null lung tumors displayed elevated expression of Ctnnb1, Ccnd1, Axin2, Lgr5, and c-Myc mRNAs, suggesting that RBMS3 silencing elevates signaling through the WNT/ß-catenin signaling axis. Although RBMS3 silencing rendered BRAFV600E-driven lung tumors resistant to the effects of dabrafenib plus trametinib, the tumors were sensitive to inhibition of porcupine, an acyltransferase of WNT ligands necessary for their secretion. Analysis of The Cancer Genome Atlas patient samples revealed that chromosome 3p24, which encompasses RBMS3, is frequently lost in non-small cell lung cancer and correlates with poor prognosis. Collectively, these data reveal the role of RBMS3 as a lung cancer suppressor and suggest that RBMS3 silencing may contribute to malignant NSCLC progression. SIGNIFICANCE: Loss of RBMS3 cooperates with BRAFV600E to induce lung tumorigenesis, providing a deeper understanding of the molecular mechanisms underlying mutant BRAF-driven lung cancer and potential strategies to more effectively target this disease.


Subject(s)
Adenocarcinoma of Lung , Carcinogenesis , Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Proto-Oncogene Proteins B-raf , RNA-Binding Proteins , Trans-Activators , Animals , Humans , Mice , Adenocarcinoma of Lung/genetics , Carcinoma, Non-Small-Cell Lung/genetics , Cell Proliferation , Lung/pathology , Lung Neoplasms/genetics , Mutagenesis , Proto-Oncogene Proteins B-raf/metabolism , RNA-Binding Proteins/genetics , Trans-Activators/metabolism , Wnt Signaling Pathway , Carcinogenesis/genetics
4.
Cancer Cell ; 40(8): 815-817, 2022 08 08.
Article in English | MEDLINE | ID: mdl-35868308

ABSTRACT

In a recent publication in Nature, Fane et al. establish WNT5A as a central, age-sensitive regulator of the dormancy-to-reactivation axis of melanoma. They show that aged fibroblasts in the lungs suppress WNT5A signaling induced at the primary tumor site to awaken dormant melanoma cells and promote the outgrowth of metastases.


Subject(s)
Aging , Lung Neoplasms , Lung , Melanoma , Aging/metabolism , Fibroblasts/metabolism , Humans , Lung/metabolism , Lung Neoplasms/pathology , Melanoma/pathology , Neoplasm Metastasis , Signal Transduction , Tumor Microenvironment , Wnt-5a Protein/metabolism
5.
Nat Commun ; 13(1): 3153, 2022 06 07.
Article in English | MEDLINE | ID: mdl-35672316

ABSTRACT

A distinct profile of NRAS mutants is observed in each tumor type. It is unclear whether these profiles are determined by mutagenic events or functional differences between NRAS oncoproteins. Here, we establish functional hallmarks of NRAS mutants enriched in human melanoma. We generate eight conditional, knock-in mouse models and show that rare melanoma mutants (NRAS G12D, G13D, G13R, Q61H, and Q61P) are poor drivers of spontaneous melanoma formation, whereas common melanoma mutants (NRAS Q61R, Q61K, or Q61L) induce rapid tumor onset with high penetrance. Molecular dynamics simulations, combined with cell-based protein-protein interaction studies, reveal that melanomagenic NRAS mutants form intramolecular contacts that enhance BRAF binding affinity, BRAF-CRAF heterodimer formation, and MAPK > ERK signaling. Along with the allelic series of conditional mouse models we describe, these results establish a mechanistic basis for the enrichment of specific NRAS mutants in human melanoma.


Subject(s)
Melanoma , Monomeric GTP-Binding Proteins/standards , Skin Neoplasms , Animals , Disease Models, Animal , GTP Phosphohydrolases/genetics , GTP Phosphohydrolases/metabolism , Melanoma/genetics , Melanoma/pathology , Membrane Proteins/genetics , Mice , Mutation , Proto-Oncogene Proteins B-raf/genetics , Proto-Oncogene Proteins B-raf/metabolism , Signal Transduction/genetics , Skin Neoplasms/genetics
6.
Int J Ind Ergon ; 86: 103216, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34566224

ABSTRACT

Study aims were to investigate how usable COVID-19 dedicated state public health websites in the US were, and whether case counts in different geographical regions in the US were related to website usability. 16 state websites representing the 2 highest and the 2 lowest case count states in each region were selected. Five experts used a heuristic evaluation procedure to independently rate all 16 websites on a severity scale of 0-4. Usability criteria published by the US Department of Health and Human Services and criteria on risk communication and data dashboards were used. Analyses involved cross tabulation of usability criteria with case counts, comparison of usability scores using Mood's median tests, test of differences in average usability scores using ANOVA and post-hoc tests, and identification of correlations between case counts and usability scores. Results from the Mood's median test showed that the median usability scores for the states were significantly different from each other at the 5% level of significance (df = 15, chi-square = 38.40; p = 0.001). ANOVA showed statistically significant differences between the mean usability scores for the states at the 5% level of significance (F = 6.33, p < 0.05). Although not statistically significant, results from a correlation analysis between case count and usability scores showed a negative correlation (r = -0.209, p = 0.437) indicating that the higher the case count, the better the usability score. Overall, the websites fared well on usability, but many websites were used as an information and data repository. These websites must communicate infection risk better. RELEVANCE TO INDUSTRY: The study applies to public health agency websites that communicate essential information during a pandemic.

7.
Life Sci Alliance ; 4(9)2021 09.
Article in English | MEDLINE | ID: mdl-34210801

ABSTRACT

BRAF-mutant melanomas are more likely than NRAS-mutant melanomas to arise in anatomical locations protected from chronic sun damage. We hypothesized that this discrepancy in tumor location is a consequence of the differential sensitivity of BRAF and NRAS-mutant melanocytes to ultraviolet light (UV)-mediated carcinogenesis. We tested this hypothesis by comparing the mutagenic consequences of a single neonatal, ultraviolet-AI (UVA; 340-400 nm) or ultraviolet-B (UVB; 280-390 nm) exposure in mouse models heterozygous for mutant Braf or homozygous for mutant Nras Tumor onset was accelerated by UVB, but not UVA, and the resulting melanomas contained recurrent mutations affecting the RING domain of MAP3K1 and Actin-binding domain of Filamin A. Melanomas from UVB-irradiated, Braf-mutant mice averaged twice as many single-nucleotide variants and five times as many dipyrimidine variants than tumors from similarly irradiated Nras-mutant mice. A mutational signature discovered in UVB-accelerated tumors mirrored COSMIC signatures associated with human skin cancer and was more prominent in Braf- than Nras-mutant murine melanomas. These data show that a single UVB exposure yields a greater burden of mutations in murine tumors driven by oncogenic Braf.


Subject(s)
Melanoma/etiology , Monomeric GTP-Binding Proteins/genetics , Mutagenesis/radiation effects , Mutation/radiation effects , Proto-Oncogene Proteins B-raf/genetics , Ultraviolet Rays/adverse effects , Animals , Biomarkers, Tumor , Disease Models, Animal , Disease Susceptibility , Genetic Predisposition to Disease , Melanoma/metabolism , Melanoma/pathology , Mice
8.
Genetica ; 148(3-4): 165-172, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32749631

ABSTRACT

Two subspecies of common reed (Phragmites australis; Poaceae) exist in northern North America: the native P. australis subsp. americanus and the introduced P. australis subsp. australis. There are numerous native populations in Wisconsin, in addition to the more recently established populations of the introduced subspecies. We studied populations of both P. australis subspecies across Wisconsin in order to characterize the genetic diversity of both subspecies and to investigate whether any instances of hybridization could be ascertained in Wisconsin. Using eight microsatellite markers, we found minimal overlap in the alleles that could be recovered from native and introduced plants, and we found no evidence to suggest hybridization between subspecies, even in localities where native and introduced plants grow in close proximity. Overall, we found greater genetic variation in plants of the introduced subspecies relative to the native subspecies, and we observed some geographic patterns of allelic diversity.


Subject(s)
Introduced Species , Poaceae/genetics , Polymorphism, Genetic , Hybridization, Genetic , Microsatellite Repeats , Wisconsin
9.
Med Sci Educ ; 30(4): 1729-1730, 2020 Dec.
Article in English | MEDLINE | ID: mdl-34457836

ABSTRACT

An investigation of the effectiveness of an emergency-responder-based program entitled "First Five Minutes" in teaching medical students the necessary assessments and procedures upon arrival to a medical crisis situation in a timely and cost-effective manner. The "First Five" includes scene safety, primary/secondary survey, airway management, basic life support (BLS)/cardiopulmonary resuscitation (CPR), and hemorrhage control.

10.
J Invest Dermatol ; 139(9): 1857-1859, 2019 09.
Article in English | MEDLINE | ID: mdl-31445573

ABSTRACT

The clinical management of large and giant congenital melanocytic nevi (lgCMN) relies heavily upon iterative surgical procedures. In this issue Rouille et al. (2019) use lgCMN explants and a newly developed patient-derived xenograft model to show that the local administration of MEK and Akt inhibitors limits the lgCMN proliferative potential. These findings, along with emerging reports, support continued investigation of targeted therapies in lgCMN.


Subject(s)
Nevus, Pigmented , Skin Neoplasms , Humans , Proto-Oncogene Proteins c-akt
11.
J Vis Exp ; (148)2019 06 26.
Article in English | MEDLINE | ID: mdl-31305511

ABSTRACT

Defects in fibroblast or melanocyte function are associated with skin diseases, including poor barrier function, defective wound healing, pigmentation defects and cancer. Vital to the understanding and amelioration of these diseases are experiments in primary fibroblast and melanocyte cultures. Nevertheless, current protocols for melanocyte isolation require that the epidermal and dermal layers of the skin are trypsinized and manually disassociated. This process is time consuming, technically challenging and contributes to inconsistent yields. Furthermore, methods to simultaneously generate pure fibroblast cultures from the same tissue sample are not readily available. Here, we describe an improved protocol for isolating melanocytes and fibroblasts from the skin of mice on postnatal days 0-4. In this protocol, whole skin is mechanically homogenized using a tissue chopper and then briefly digested with collagenase and trypsin. Cell populations are then isolated through selective plating followed by G418 treatment. This procedure results in consistent melanocyte and fibroblast yields from a single mouse in less than 90 min. This protocol is also easily scalable, allowing researchers to process large cohorts of animals without a significant increase in hands-on time. We show through flow cytometric assessments that cultures established using this protocol are highly enriched for melanocytes or fibroblasts.


Subject(s)
Cell Culture Techniques/methods , Fibroblasts/cytology , Melanocytes/cytology , Animals , Cells, Cultured , Female , Humans , Male , Mice, Inbred C57BL , Time Factors
12.
J Virol ; 90(7): 3760-72, 2016 Jan 27.
Article in English | MEDLINE | ID: mdl-26819304

ABSTRACT

UNLABELLED: Human T-cell leukemia virus type 1 (HTLV-1) and type 2 (HTLV-2) are highly related retroviruses that transform T cells in vitro but have distinct pathological outcomes in vivo. HTLV-1 encodes a protein from the antisense strand of its proviral genome, the HTLV-1 basic leucine zipper factor (HBZ), which inhibits Tax-1-mediated viral transcription and promotes cell proliferation, a high proviral load, and persistence in vivo. In adult T-cell leukemia/lymphoma (ATL) cell lines and patient T cells, hbz is often the only viral gene expressed. The antisense strand of the HTLV-2 proviral genome also encodes a protein termed APH-2. Like HBZ, APH-2 is able to inhibit Tax-2-mediated viral transcription and is detectable in most primary lymphocytes from HTLV-2-infected patients. However, unlike HBZ, the loss of APH-2 in vivo results in increased viral replication and proviral loads, suggesting that HBZ and APH-2 modulate the virus and cellular pathways differently. Herein, we examined the effect of APH-2 on several known HBZ-modulated pathways: NF-κB (p65) transactivation, transforming growth factor ß (TGF-ß) signaling, and interferon regulatory factor 1 (IRF-1) transactivation. Like HBZ, APH-2 has the ability to inhibit p65 transactivation. Conversely, HBZ and APH-2 have divergent effects on TGF-ß signaling and IRF-1 transactivation. Quantitative PCR and protein half-life experiments revealed a substantial disparity between HBZ and APH-2 transcript levels and protein stability, respectively. Taken together, our data further elucidate the functional differences between HBZ and APH-2 and how these differences can have profound effects on the survival of infected cells and, ultimately, pathogenesis. IMPORTANCE: Human T-cell leukemia virus type 1 (HTLV-1) and type 2 (HTLV-2) are highly related retroviruses that have distinct pathological outcomes in infected hosts. Functional comparisons of HTLV-1 and HTLV-2 proteins provide a better understanding about how HTLV-1 infection is associated with disease and HTLV-2 infection is not. The HTLV genome antisense-strand genes hbz and aph-2 are often the only viral genes expressed in HTLV-infected T cells. Previously, our group found that HTLV-1 HBZ and HTLV-2 APH-2 had distinct effects in vivo and hypothesized that the differences in the interactions of HBZ and APH-2 with important cell signaling pathways dictate whether cells undergo proliferation, apoptosis, or senescence. Ultimately, these functional differences may affect how HTLV-1 causes disease but HTLV-2 generally does not. In the current study, we compared the effects of HBZ and APH-2 on several HTLV-relevant cellular pathways, including the TGF-ß signaling, NF-κB activation, and IRF-1 transactivation pathways.


Subject(s)
Host-Pathogen Interactions , Human T-lymphotropic virus 1/physiology , Viral Proteins/metabolism , Cell Line , Gene Expression Regulation, Viral , Human T-lymphotropic virus 1/pathogenicity , Humans , Real-Time Polymerase Chain Reaction , Transcription Factor RelA/antagonists & inhibitors
13.
Nature ; 488(7413): 609-14, 2012 Aug 30.
Article in English | MEDLINE | ID: mdl-22932385

ABSTRACT

Atmospheric carbon dioxide concentrations and climate are regulated on geological timescales by the balance between carbon input from volcanic and metamorphic outgassing and its removal by weathering feedbacks; these feedbacks involve the erosion of silicate rocks and organic-carbon-bearing rocks. The integrated effect of these processes is reflected in the calcium carbonate compensation depth, which is the oceanic depth at which calcium carbonate is dissolved. Here we present a carbonate accumulation record that covers the past 53 million years from a depth transect in the equatorial Pacific Ocean. The carbonate compensation depth tracks long-term ocean cooling, deepening from 3.0-3.5 kilometres during the early Cenozoic (approximately 55 million years ago) to 4.6 kilometres at present, consistent with an overall Cenozoic increase in weathering. We find large superimposed fluctuations in carbonate compensation depth during the middle and late Eocene. Using Earth system models, we identify changes in weathering and the mode of organic-carbon delivery as two key processes to explain these large-scale Eocene fluctuations of the carbonate compensation depth.


Subject(s)
Altitude , Calcium Carbonate/analysis , Carbon Cycle , Seawater/chemistry , Atmosphere/chemistry , Carbon Dioxide/analysis , Diatoms/metabolism , Foraminifera/metabolism , Geologic Sediments/chemistry , Global Warming/history , Global Warming/statistics & numerical data , History, 21st Century , History, Ancient , Marine Biology , Oxygen/metabolism , Pacific Ocean , Temperature
14.
Bioorg Med Chem ; 19(8): 2596-602, 2011 Apr 15.
Article in English | MEDLINE | ID: mdl-21458277

ABSTRACT

Aggregation of the amyloid-ß protein (Aß) plays a pathogenic role in the progression of Alzheimer's disease, and small molecules that attenuate Aß aggregation have been identified toward a therapeutic strategy that targets the disease's underlying cause. Compounds containing aromatic structures have been repeatedly reported as effective inhibitors of Aß aggregation, but the functional groups that influence inhibition by these aromatic centers have been less frequently explored. The current study identifies analogs of naturally occurring coumarin as novel inhibitors of Aß aggregation. Derivatization of the coumarin structure is shown to affect inhibitory capabilities and to influence the point at which an inhibitor intervenes within the nucleation dependent Aß aggregation pathway. In particular, functional groups found within amyloid binding dyes, such as benzothiazole and triazole, can improve inhibition efficacy. Furthermore, inhibitor intervention at early or late stages within the amyloid aggregation pathway is shown to correlate with the ability of these functional groups to recognize and bind amyloid species that appear either early or late within the aggregation pathway. These results demonstrate that functionalization of small aromatic molecules with recognition elements can be used in the rational design of Aß aggregation inhibitors to not only enhance inhibition but to also manipulate the inhibition mechanism.


Subject(s)
Amyloid beta-Peptides/metabolism , Coumarins/chemistry , Coumarins/pharmacology , Amyloid beta-Peptides/drug effects , Drug Design , Humans , Protein Binding/drug effects , Protein Multimerization/drug effects , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...